Last update 01 Nov 2024

XL-888

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target
Mechanism
HSP90B inhibitors(Heat shock protein HSP 90-beta inhibitors)
Active Indication
Originator Organization
Inactive Organization
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC29H37N5O3
InChIKeyLHGWWAFKVCIILM-HLRQEUIKSA-N
CAS Registry1149705-71-4

External Link

KEGGWikiATCDrug Bank
---

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Adenocarcinoma of large intestinePhase 2
US
07 Jul 2017
Adenocarcinoma of large intestinePhase 2
US
07 Jul 2017
Colorectal cancer recurrentPhase 2
US
07 Jul 2017
Colorectal cancer recurrentPhase 2
US
07 Jul 2017
Colorectal Cancer, Hereditary Nonpolyposis, Type 1Phase 2
US
07 Jul 2017
Colorectal Cancer, Hereditary Nonpolyposis, Type 1Phase 2
US
07 Jul 2017
Pancreatic adenocarcinoma metastaticPhase 2
US
07 Jul 2017
Pancreatic adenocarcinoma metastaticPhase 2
US
07 Jul 2017
Pancreatic carcinoma non-resectablePhase 2
US
07 Jul 2017
Unresectable MelanomaPhase 1
US
27 Jul 2012
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
16
(oqadgmavzd) = qhkftaspps qktyfreiwp (tnhddpzqyq )
Negative
27 Jun 2024
Phase 1
Colorectal Cancer
RAS | BRAF | HER2 amplification
16
(wdexhfecuu) = ajxuxvmjks wdrcfjetrn (tawisuxlgy, 3.0 - 9.9)
Negative
20 Jun 2024
Phase 1/2
-
xixgwxgzdr(ylfnmhoscp) = htyhqrdaok ampakccyya (vmzrxhaonw )
Positive
10 Dec 2020
xixgwxgzdr(ylfnmhoscp) = kptpclrtzz ampakccyya (vmzrxhaonw )
Phase 1
-
(gteswspuiu) = XL888 90 mg twice weekly combined with P 200 mg, every 3 weeks iukedcwyjl (ewnderplff )
Positive
23 Jan 2020
Phase 1
25
tdowfibsmx(qwkbypyspq) = 3 DLTs (rash) in 12 pts were observed in the XL888 60 mg cohort, which was determined as the maximum tolerated dose xqfqefvwui (joauyjguwu )
Negative
26 May 2019
Phase 1
Metastatic melanoma
BRAF V600 Mutation
19
(vaxhxxsnaj) = zdzvgfgokz fnkdmxlxhw (ijwjokftif, 3.7 - 16.2)
Positive
04 Jun 2016
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free